A stock's price target isn't just a number, it's a claim about where a company is headed and why. 24/7 Wall St's Price Targets desk publishes our own price projections for individual stocks, built from company fundamentals, growth drivers, and risk factors, alongside real-time tracking of Wall Street analyst price target changes, upgrades, and downgrades. We show you both what the Street thinks and what we think, so you can judge a stock's path for yourself.
The Price Targets desk runs on two tracks. First, we build our own price projections for individual stocks using company fundamentals, growth catalysts, competitive position, and downside risks, laid out in bull, base, and bear scenarios. Second, we track Wall Street analyst price target changes as they happen, flagging upgrades, downgrades, and the reasoning behind them. Our goal is not to hand you a number, but to show you the case behind it, so you can decide how much weight it deserves.
Costco just posted its fifth consecutive earnings beat and carries a renewal rate that almost no retailer can match, yet the stock sits well off its highs. Our model reveals whether that gap is…
Coca-Cola has beaten earnings five straight quarters and raised its guidance, yet a pending IRS ruling and a price-to-free-cash-flow ratio of 71 hang over the stock like a storm cloud. Here is what the…
Adobe's stock has collapsed while its revenue keeps hitting records, and Wall Street is stuck in a holding pattern. A specific combination of catalysts could change that calculus dramatically before 2027 is over.
Meta is spending more than a hundred billion dollars on AI while free cash flow has cratered and earnings missed expectations, yet a five-year price model still sees your stake growing substantially. The question…
Bank of America just raised price targets on two pharma giants facing patent cliffs, but its conviction level differs sharply between them, and the valuation gap may explain which one belongs in a long-term…
Figma shares sit near a 52-week low even as revenue growth keeps accelerating, leaving a glaring gap between price and fundamentals that either signals a rare buying opportunity or a warning investors are missing…
Eli Lilly is growing faster than any other mega-cap drugmaker, but a pipeline drug still awaiting approval and falling U.S. prices are pulling the stock in opposite directions. The outcome of that tension shapes…
Nvidia gets the headlines, but the company quietly linking all those GPUs together just posted 115% revenue growth and added optics as a second major growth engine. Here is the case for a 2027…
Wall Street is split on Netflix after a brutal year for the stock, but Deutsche Bank just broke from the crowd with an upgrade built on a part of the business most investors are…
Salesforce shares have shed double digits this year while Wall Street quietly revised its earnings estimates sharply higher, creating a gap between price and fundamentals that few investors are watching closely enough.
JPMorgan sees multiple levers working in Micron's favor before its September 30 earnings report, but the stock has a troubling habit of selling off sharply even after big beats. Here is what separates a…
AMD just crossed into the trillion-dollar club on the back of one market that management believes will grow to $1.4 trillion by 2030, but the stock already trades near a 52-week high and carries…
AWS is growing faster and minting higher margins than almost any business Amazon has ever built, yet the stock sits well below what that trajectory implies. Here is why the gap between today's price…
Palantir has already made some investors rich, but the next five years come with wildly different outcomes depending on which scenario plays out. Here is how a simple monthly plan stacks up against each…
Alphabet is running multiple growth engines at once, from a cloud business expanding at breakneck speed to an AI platform already reaching nearly a billion users, yet the stock still trades at a discount…
